Article 2: Evolution of the Biosimilars Industry
Our first white paper, Biosimilars Come of Age, highlighted growth in Biosimilars from 2015 to 2020.
Handling of COVID-19 infection in Employees – Summary Report (Jun-20)
Based on FDA guidance on GMP considerations for Responding to COVID-19 infection in employees in Drug and Biological Products Manufacturing
Article 1: Biosimilars Come of Age
In the 1990s, it was “generic biologics”. In the early 2000s, “follow-on biologics”. Starting in 2006 regulators settled on the word “biosimilars.” The goal was always the same..
IBPS Covid-19 CT Update III (05-May-20)
IBPS and SBLehrer LLC are releasing the next update of clinical efforts for treatments and vaccines for Covid19
IBPS Covid-19 CT Update II (04-Apr-20)
IBPS and SBLehrer LLC are releasing the next update of clinical efforts for treatments and vaccines for Covid19.